Paper39201502
BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation.
Serebrenik AA and 5 others. Int J Mol Sci, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation. Papers, record 39201502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201502
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Whole-Body Irradiation | Major topic |
| Transcriptome | Major topic |
| Animals | |
| Mice | |
| Male | |
| Radiation-Protective Agents | |
| Gene Expression Profiling | |
| Biomarkers | |
| Gene Expression Regulation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1I80 VP00262-01 | Joint Program Committee-7/Radiation Health Effects Research Program (RHERP) | I80VP002620 | PubMed | NIH RePORTER | |
| AFR-B4-10978, AFR-12080 | Uniformed Services University of the Health Sciences/Armed Forces Radiobiology Research Institute | PubMed | PubMed |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32960660 | Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model. | Int J Radiat Biol | 2021 | https://conductscience.org/library/papers/32960660 | PubMed |
| 2 | 28650707 | A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. | Int J Radiat Biol | 2017 | https://conductscience.org/library/papers/28650707 | PubMed |
| 3 | 31216213 | Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. | Int J Radiat Biol | 2020 | https://conductscience.org/library/papers/31216213 | PubMed |
| 4 | 7251416 | Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. | Int J Radiat Oncol Biol Phys | 1981 | https://conductscience.org/library/papers/7251416 | PubMed |
| 5 | 22468702 | Animal models and medical countermeasures development for radiation-induced lung damage: report from an NIAID Workshop. | Radiat Res | 2012 | https://conductscience.org/library/papers/22468702 | PubMed |
| 6 | 26488033 | Filgrastim for the treatment of hematopoietic acute radiation syndrome. | Drugs Today (Barc) | 2015 | https://conductscience.org/library/papers/26488033 | PubMed |
| 7 | 29379499 | S100 Proteins As an Important Regulator of Macrophage Inflammation. | Front Immunol | 2017 | https://conductscience.org/library/papers/29379499 | PubMed |
| 8 | 36301689 | Safety, Pharmacokinetics, and Biomarkers of an Amorphous Solid Dispersion of Genistein, a Radioprotectant, in Healthy Volunteers. | Clin Pharmacol Drug Dev | 2023 | https://conductscience.org/library/papers/36301689 | PubMed |
| 9 | 28963717 | BIO 300, a nanosuspension of genistein, mitigates pneumonitis/fibrosis following high-dose radiation exposure in the C57L/J murine model. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/28963717 | PubMed |
| 10 | 23210705 | Filgrastim improves survival in lethally irradiated nonhuman primates. | Radiat Res | 2013 | https://conductscience.org/library/papers/23210705 | PubMed |
| 11 | 37224926 | Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule. | Int J Radiat Oncol Biol Phys | 2023 | https://conductscience.org/library/papers/37224926 | PubMed |
| 12 | 31038675 | Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome. | J Radiat Res | 2019 | https://conductscience.org/library/papers/31038675 | PubMed |
| 13 | 36090752 | Lung transcriptome of nonhuman primates exposed to total- and partial-body irradiation. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/36090752 | PubMed |
| 14 | 24695404 | Trimmomatic: a flexible trimmer for Illumina sequence data. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24695404 | PubMed |
| 15 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 16 | 26035709 | Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates. | Radiat Res | 2015 | https://conductscience.org/library/papers/26035709 | PubMed |
| 17 | 30624357 | Proteomic Evaluation of the Acute Radiation Syndrome of the Gastrointestinal Tract in a Murine Total-body Irradiation Model. | Health Phys | 2019 | https://conductscience.org/library/papers/30624357 | PubMed |
| 18 | 23558742 | The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23558742 | PubMed |
| 19 | 37217865 | Transcriptome profile changes in the jejunum of nonhuman primates exposed to supralethal dose of total- or partial-body radiation. | BMC Genomics | 2023 | https://conductscience.org/library/papers/37217865 | PubMed |
| 20 | 37652301 | Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. | Int J Radiat Oncol Biol Phys | 2024 | https://conductscience.org/library/papers/37652301 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| S100A1 | 6271 | PubTator's text mining | https://conductscience.org/library/genes/6271 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201502
GET https://conductscience.org/api/papers/v1/39201502/references?page=2